Read our Brand Guidelines for logo, font and brand colors.
Download high resolution images of FourHealth product and logos.



Conversation points:

  • Poor heart health (cardiovascular disease) is a chronic inflammatory condition.

  • Oxidative stress and chronic inflammation co-exist.

  • Sulforaphane upregulates the production of the body’s antioxidants, reducing oxidative stress, and therefore chronic inflammation.

  • Scientific studies show Sulforaphane supports reduced cholesterol, cholesterol oxidation, reduces arterial inflammation, and supports the reduction in artheroscleroitc lesions.


Conversation points:

  • AGES are common in diet, present in people with pre-diabetes or diabetes, and harmful.

  • AGES cause oxidative stress and inflammation, which can lead to vascular damage.

  • SFN reduces oxidative stress.

    In scientific studies, SFN:

  • Reduces markers for inflammation.

  • Improves blood glucose control.

  • Restores vascular and endothelial function.


Conversation points:

  • Excess oestrogen can cause symptoms, especially prior to and during periods.

  • The liver, specifically the Phase II Liver detox process, is primarily responsible for breaking down all Oestrogen types and its metabolites.

  • Sulforaphane has been shown to support Phase II Liver detox, and the clearance of Oestrogen and its metabolites.

  • Case studies suggest it typically takes up to 3 months using FourHealth Green+ to fully realise the symptom benefits.


Conversation points:

  • Oxidative stress is present in most respiratory illnesses, as demonstrated by Glutathione depletion in the lungs.

  • FourHealth Green+ supports the bodies production of Glutathione and other antioxidants.

  • Scientific studies show that after taking FourHealth Green+, the body increases the supply of antioxidants to the lungs, supporting improved lung function.


  • Asthma, 18 mg dose

    Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways.

    Brown, Respir Res. 2015; 16(1): 106.

    Learn more
  • Autism, 9-14 mg dose

    Sulforaphane treatment of autism spectrum disorder (ASD).

    Singh et al, Proc Natl Acad Sci U S A. 2014 Oct 28; 111(43): 15550-5.

    Learn more
  • COPD, 19 mg dose

    Oral Sulforaphane increases Phase II antioxidant enzymes in the human upper airway.

    Reidl, Clin Immunol. 2009 Mar; 130(3): 244–251.

    Learn more
  • Cholesterol

    Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials.

    Armah, Mol Nutr Food Res. 2015 May; 59(5): 918–926.

    Learn more
  • Detoxification of atmospheric pollutants,32 mg dose

    Rapid and Sustainable Detoxication of Airborne Pollutants by Broccoli Sprout Beverage: Results of a Randomized Clinical Trial in China. 

    Cancer Prev Res (Phila). 2014 Aug; 7(8): 813-823.

    Learn more
  • Heliocobacter pylori infection, 24 mg dose

    High-sulforaphane broccoli sprout powder reduces serum nitric oxide metabolites in Helicobacter pylori infected patients.

    Journal of Functional Foods 34: 356-358 July 2017.

    Learn more
  • Nasal allergy response, 18mg dose

    Sulforaphane-rich broccoli sprout extract attenuates nasal allergic response to diesel exhaust particles.

    Heber, Food Funct. 2014 Jan; 5(1): 35-41.

    Learn more
  • Prostate disease (PSA doubling time), 60 mg dose

    A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.

    Invest New Drugs. 2015 Apr; 33(2): 480–489.

    Learn more
  • Constipation, 5 mg dose

    Daily intake of broccoli sprouts normalizes bowel habits in human healthy subjects.

    Yanaka, J Clin Biochem Nutr. 2018 Jan; 62(1): 75-82.

    Learn more
  • Type II Diabetes, 40 mg dose

    Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial.

    Bahadoran, Journal of Functional Foods, Volume 4, Issue 4, October 2012, Pages 837-841.

    Learn more
  • Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality?

    Christine A. Houghton, Robert G. Fassett, Jeff S. Coombes, Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7857186, 17 pages, 2016.

    Learn more
  • Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease

    Christine A. Houghton, Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 2716870, 27 pages, 2019.

    Learn more